Variant report
Variant | nsv605008 |
---|---|
Chromosome Location | chr6:161253485-161270619 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:6)
- LncRNA region (count:5)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:6 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:161248150..161249930-chr6:161255516..161257589,2 | K562 | blood: | |
2 | chr6:161260541..161262340-chr6:161262561..161265121,3 | K562 | blood: | |
3 | chr6:161260541..161262340-chr6:161262561..161265121,3 | K562 | blood: | |
4 | chr6:161250769..161254707-chr6:161411304..161414099,3 | K562 | blood: | |
5 | chr6:161266955..161270556-chr6:161271678..161274838,4 | K562 | blood: | |
6 | chr6:161255639..161258104-chr6:161293113..161295110,2 | K562 | blood: |
(count:5 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-PLG-3 | chr6:161268128-161268254 | l_3310_chr6:161267548-161283742_testes |
2 | lnc-PLG-3 | chr6:161268016-161268184 | NONHSAT115916 |
3 | lnc-PLG-3 | chr6:161267549-161267600 | l_3310_chr6:161267548-161283742_testes |
4 | lnc-PLG-3 | chr6:161267391-161267600 | NONHSAT115916 |
5 | lnc-PLG-3 | chr6:161268885-161269038 | l_3310_chr6:161267548-161283742_testes |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000272841 | chromatin interactions |
ENSG00000085511 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs1247541 | chr6:161253485-161253486 | Inactive region | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs186344358 | chr6:161253486-161253487 | Inactive region | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
3 | rs74429501 | chr6:161253546-161253547 | Inactive region | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
4 | rs200441821 | chr6:161253678-161253679 | Inactive region | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
5 | rs62435267 | chr6:161253683-161253684 | Inactive region | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
6 | rs572147349 | chr6:161253730-161253731 | Inactive region | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
7 | rs569692951 | chr6:161253764-161253765 | Inactive region | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
8 | rs564093568 | chr6:161253775-161253776 | Inactive region | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
9 | rs138861506 | chr6:161253801-161253802 | Inactive region | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
10 | rs114213314 | chr6:161253895-161253896 | Inactive region | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
11 | rs572786550 | chr6:161253946-161253947 | Inactive region | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
12 | rs544824644 | chr6:161253947-161253948 | Inactive region | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
13 | rs192056523 | chr6:161253992-161253993 | Inactive region | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
14 | rs575443190 | chr6:161254023-161254024 | Inactive region | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
15 | rs537099672 | chr6:161254053-161254054 | Inactive region | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
16 | rs561270792 | chr6:161254293-161254294 | Inactive region | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
17 | rs530357166 | chr6:161254308-161254309 | Inactive region | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
18 | rs552307374 | chr6:161254355-161254356 | Inactive region | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
19 | rs540908634 | chr6:161254400-161254401 | Inactive region | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
20 | rs560327660 | chr6:161254402-161254403 | Inactive region | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
21 | rs1652471 | chr6:161254403-161254404 | Inactive region | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
22 | rs552398086 | chr6:161254491-161254492 | Inactive region | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
23 | rs569335963 | chr6:161254553-161254554 | Inactive region | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
24 | rs183375760 | chr6:161254645-161254646 | Inactive region | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
25 | rs550823022 | chr6:161254662-161254663 | Inactive region | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
26 | rs567452994 | chr6:161254677-161254678 | Inactive region | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
27 | rs55706744 | chr6:161254680-161254681 | Inactive region | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
28 | rs115313344 | chr6:161254683-161254684 | Inactive region | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
29 | rs367674788 | chr6:161258255-161258256 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
30 | rs551605275 | chr6:161258310-161258311 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
31 | rs545563841 | chr6:161258363-161258364 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
32 | rs530282759 | chr6:161258371-161258372 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
33 | rs138086208 | chr6:161258435-161258436 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs531531102 | chr6:161258452-161258453 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs183626163 | chr6:161258460-161258461 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs117622052 | chr6:161258489-161258490 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs375440413 | chr6:161258496-161258497 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs143865500 | chr6:161258605-161258606 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
39 | rs55777945 | chr6:161258658-161258659 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
40 | rs565128254 | chr6:161258679-161258680 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
41 | rs547477211 | chr6:161258695-161258696 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
42 | rs570416881 | chr6:161258723-161258724 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
43 | rs148603325 | chr6:161258731-161258732 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
44 | rs202216646 | chr6:161258761-161258762 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
45 | rs550426076 | chr6:161258768-161258769 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
46 | rs570248020 | chr6:161258774-161258775 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
47 | rs536197435 | chr6:161258792-161258793 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
48 | rs9355842 | chr6:161267442-161267443 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs575424352 | chr6:161267443-161267444 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
50 | rs193038882 | chr6:161267457-161267458 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Ependymoma | 16718352 | CNVD |
Gastric cancer | 17908304 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Developmental delay | 19490664 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Leukemia | 18688285 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Esophageal cancer | 21851588 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Breast cancer | 17133270 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Developmental delay | 21147756 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Chordoma | 18071362 | CNVD |
Breast cancer | 21509527 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Autism | 22241247 | CNVD |
Breast cancer | 16397240 | CNVD |
Atherosclerosis | 21956041 | CNVD |
Maculopathy | 20981449 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Astrocytoma | 16205629 | CNVD |
Parkinson disease | 17160897 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:161258200-161258400 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
2 | chr6:161258200-161258400 | ZNF genes & repeats | H1 Derived Mesenchymal Stem Cells | ES cell derived |
3 | chr6:161258200-161258600 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
4 | chr6:161258600-161258800 | Bivalent Enhancer | Fetal Adrenal Gland | Adrenal Gland |